Scientific Reports · 2013 · 332 citations · 19 references
PharmacyBioinformaticsMedicinal ChemistryComputational BiologyDrug DesignDrug DiscoveryComputational Drug DiscoveryComputational OncologyPeptide AnalysisPeptide Drug DiscoveryPeptide IdentificationVirtual ScreeningAmino Acid Composition AnalysisComputational Biology ModelsComputational Peptide DesignComputational Prediction ModelsComputational ScreeningComputer-aided Drug DiscoverySupport Vector ClassificationTherapeutic Peptides
Use of therapeutic peptides in cancer therapy has been receiving considerable attention in the recent years. Present study describes the development of computational models for predicting and discovering novel anticancer peptides. Preliminary analysis revealed that Cys, Gly, Ile, Lys, and Trp are dominated at various positions in anticancer peptides. Support vector machine models were developed using amino acid composition and binary profiles as input features on main dataset that contains experimentally validated anticancer peptides and random peptides derived from SwissProt database. In addition, models were developed on alternate dataset that contains antimicrobial peptides instead of random peptides. Binary profiles-based model achieved maximum accuracy 91.44% with MCC 0.83. We have developed a webserver, which would be helpful in: (i) predicting minimum mutations required for improving anticancer potency; (ii) virtual screening of peptides for discovering novel anticancer peptides, and (iii) scanning natural proteins for identification of anticancer peptides (http://crdd.osdd.net/raghava/anticp/).
19
WebLogo: A Sequence Logo Generator: Figure 1
Gavin E. Crooks, Gary C. Hon, John‐Marc Chandonia et al. · Genome Research · 2004 · 13K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Anti-cancer activity of targeted pro-apoptotic peptides
H. Michael Ellerby, Wadih Arap, Lisa Ellerby et al. · Nature Medicine · 1999 · 930 citations